acetylcysteine has been researched along with Coronary Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (16.00) | 18.7374 |
| 1990's | 4 (16.00) | 18.2507 |
| 2000's | 14 (56.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chukhliaev, PV; Garbuzov, AA; Khavkina, DA; Ploskireva, AA; Ruzhentsova, TA | 1 |
| Akbarzadeh, S; Anvaripour, A; Bahtoei, M; Iranpour, D; Movahed, A; Netticadan, T; Ostovar, A; Raj, P; Shafiei, E; Shahryari, H; Tahmasebi, R | 1 |
| Aublet-Cuvelier, B; Cellarier, E; Decalf, V; Deteix, P; Heng, AE; Marcaggi, X; Motreff, P; Souweine, B | 1 |
| Alihanoglu, Y; Aygul, MU; Ayhan, S; Dogdu, O; Erkorkmaz, U; Gunebakmaz, O; Kalay, N; Karabag, T; Kaya, MG; Kayrak, M; Koc, F; Ozdemir, K; Sonmez, O; Vatankulu, MA | 1 |
| Cheng, JJ; Kuan, P; Shyu, KG | 1 |
| Caputo, C; Dokko, J; Durham, JD; Dutka, P; Fishbane, S; Keltz, J; Maesaka, JK; Marzo, K; Pahlavan, M; Zaharakis, T | 1 |
| Akinwande, AO; Blankenship, JA; Campbell, B; Mouhayar, EN; Tadros, GM; Wood, C | 1 |
| Boitte, S; De Kock, M; Hanet, CE; Kefer, JM; Wilmotte, L | 1 |
| Al Shamari, A; Buller, CE; Fox, RS; Humphries, KH; Levin, A; Pate, GE; Shalansky, S; Sutander, A; Webb, JG; Williams, T | 1 |
| Atchison, D; Barolet, A; Daly, P; Dzavik, V; Ing, D; Lewycky, P; McLaughlin, PR; Miner, SE; Mitchell, J; Nguyen-Ho, P; Richardson, R; Ross, J; Schwartz, L; Seidelin, P | 1 |
| Azmus, AD; Bulcão, L; Duro, K; Frey, M; Gottschall, C; Lima, C; Manica, A; Manica, J | 1 |
| Aydogdu, S; Diker, E; Eraslan, H; Gulel, O; Keles, T; Ulusoy, V | 1 |
| Blasco, M; Bodí, V; Carbonell, N; García-Ramón, R; Insa, L; Miguel, A; Núñez, J; Pérez-Sancho, E; Sanchis, J; Sanjuán, R | 1 |
| Banerjee, D; Chaparro, M; Cózar, R; Cruz, JM; Cubero, J; Kaski, JC; Méndez, I; Prado, B; Recio-Mayoral, A | 1 |
| Barańska-Kosakowska, A; Przybylski, R; Zakliczyński, M; Zembala, M | 1 |
| Alscher, DM; Brenner, S; Butscheid, M; Kimmel, M; Klotz, U; Kuhlmann, U | 1 |
| Bouzas-Mosquera, A; Vázquez-Rodríguez, JM | 1 |
| De Servi, S; Eleuteri, E; Ghio, S; Montemartini, C; Perotti, R; Specchia, G | 1 |
| Kanki, H; Nishikawa, Y; Ogawa, S | 1 |
| Colombo, A; Licciardello, L; Lodola, E; Marchetti, G | 1 |
| Alberola, A; Gil, F; Morcillo, EJ; Such, L; Zaragoza, R | 1 |
| Bodemann, T; Hochrein, H; Langescheid, C | 1 |
| Black, WH; Hillis, LD; Lee, HR; Levine, BD; May, DC; Popma, JJ; Schaefer, S | 1 |
| Cunningham, M; Loscalzo, J; Stamler, J | 1 |
| Albertini, A; Cargnoni, A; Ceconi, C; Curello, S; Ferrari, R; Visioli, O | 1 |
1 review(s) available for acetylcysteine and Coronary Disease
| Article | Year |
|---|---|
Use of N-acetylcysteine in the management of coronary artery diseases.
Topics: Acetylcysteine; Angina, Unstable; Animals; Clinical Trials as Topic; Coronary Disease; Drug Evaluation, Preclinical; Drug Therapy, Combination; Free Radical Scavengers; Humans; Nitroglycerin; Vasodilator Agents | 1999 |
16 trial(s) available for acetylcysteine and Coronary Disease
| Article | Year |
|---|---|
Effects of N-acetyl cysteine and melatonin on early reperfusion injury in patients undergoing coronary artery bypass grafting: A randomized, open-labeled, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Aged; Antioxidants; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Drug Monitoring; Female; Humans; Male; Melatonin; Middle Aged; Myocardial Reperfusion Injury; Oxidative Stress; Treatment Outcome | 2018 |
Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Kidney Diseases; Male; Prospective Studies; Sodium Bicarbonate; Treatment Outcome; Triiodobenzoic Acids | 2008 |
Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Female; Fluid Therapy; Follow-Up Studies; Free Radical Scavengers; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure.
Topics: Acetylcysteine; Aged; Comorbidity; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Free Radical Scavengers; Humans; Iopamidol; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies | 2002 |
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Coronary Disease; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Incidence; Male; Middle Aged; Prospective Studies | 2002 |
Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Biomarkers; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Free Radical Scavengers; Humans; Kidney Failure, Chronic; Male; Middle Aged; Prospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Single-Blind Method; Stroke Volume; Treatment Outcome | 2003 |
A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect.
Topics: Acetylcysteine; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Treatment Failure | 2004 |
N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Diabetes Complications; Double-Blind Method; Female; Follow-Up Studies; Humans; Kidney Diseases; Male; Middle Aged | 2004 |
Effectiveness of acetylcysteine in prevention of contrast nephropathy.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Blood Urea Nitrogen; Brazil; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Double-Blind Method; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Osmolar Concentration; Prospective Studies; Stroke Volume; Treatment Outcome | 2005 |
Prophylactic acetylcysteine usage for prevention of contrast nephropathy after coronary angiography.
Topics: Acetylcysteine; Aged; Antioxidants; Blood Urea Nitrogen; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2005 |
Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Double-Blind Method; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Middle Aged; Prospective Studies; Protective Agents | 2007 |
The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study.
Topics: Acetylcysteine; Aged; Angioplasty, Balloon, Coronary; Coronary Disease; Emergency Medical Services; Female; Fluid Therapy; Humans; Male; Middle Aged; Prospective Studies; Single-Blind Method; Sodium Bicarbonate | 2007 |
Role of N-acetylcysteine on renal function in patients after orthotopic heart transplantation undergoing coronary angiography.
Topics: Acetylcysteine; Adult; Aged; Cardiac Catheterization; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Female; Heart Transplantation; Humans; Kidney; Male; Middle Aged; Postoperative Complications; Prospective Studies | 2007 |
Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
Topics: Acetylcysteine; Administration, Oral; Aged; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Cystatin C; Cystatins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Free Radical Scavengers; Glomerular Filtration Rate; Humans; Injections, Intravenous; Iopamidol; Male; Protease Inhibitors; Renal Insufficiency; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Zinc Compounds | 2008 |
[Different susceptibilities to the development of nitroglycerin tolerance in the human peripheral venous and arterial circulations].
Topics: Acetylcysteine; Analysis of Variance; Arteries; Blood Circulation; Coronary Disease; Drug Interactions; Drug Tolerance; Hemodynamics; Humans; Infusions, Intravenous; Nitroglycerin; Time Factors; Veins | 1994 |
Differential effects of N-acetylcysteine on nitroglycerin- and nicorandil-induced vasodilation in human coronary circulation.
Topics: Acetylcysteine; Coronary Circulation; Coronary Disease; Coronary Vessels; Female; Free Radical Scavengers; Hemodynamics; Humans; Male; Middle Aged; Niacinamide; Nicorandil; Nitroglycerin; Vasodilation; Vasodilator Agents | 1998 |
8 other study(ies) available for acetylcysteine and Coronary Disease
| Article | Year |
|---|---|
[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
Topics: Acetylcysteine; Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Atrial Fibrillation; Azithromycin; Cohort Studies; Comorbidity; Coronary Disease; COVID-19; COVID-19 Drug Treatment; Dabigatran; Disseminated Intravascular Coagulation; Female; Humans; Hypertension; Indoles; Interferon alpha-2; Intracranial Arteriosclerosis; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; SARS-CoV-2; Severity of Illness Index; Survival Analysis | 2021 |
Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.
Topics: Acetylcysteine; Acute Kidney Injury; Aged; Analysis of Variance; Case-Control Studies; Contrast Media; Coronary Angiography; Coronary Disease; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Kidney Function Tests; Male; Middle Aged; Multivariate Analysis; Probability; Prospective Studies; Radiopharmaceuticals; Reference Values; Treatment Outcome | 2003 |
Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.
Topics: Acetylcysteine; Contrast Media; Coronary Disease; Diagnostic Techniques, Cardiovascular; Free Radical Scavengers; Humans; Prognosis; Renal Insufficiency; Risk Factors; Sodium Bicarbonate | 2008 |
Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart.
Topics: Acetylcysteine; Animals; Coronary Circulation; Coronary Disease; Disease Models, Animal; Dogs; Female; Glutathione; Male; Myocardial Infarction; Time Factors | 1991 |
[Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
Topics: Acetylcysteine; Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin | 1989 |
In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries.
Topics: Acetylcysteine; Adult; Aged; Arteries; Coronary Circulation; Coronary Disease; Coronary Vessels; Drug Tolerance; Female; Humans; Infusions, Intravenous; Injections, Intra-Arterial; Male; Middle Aged; Nitroglycerin; Sulfhydryl Compounds | 1987 |
Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Blood Platelets; Coronary Disease; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin; Oxidation-Reduction; Platelet Aggregation; Sulfhydryl Compounds | 1988 |
The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine.
Topics: Acetylcysteine; Animals; Coronary Disease; Creatine Kinase; Free Radicals; Glutathione; Lactates; Mitochondria, Heart; Perfusion; Rabbits | 1988 |